Application 204741
- Type
- ANDA
- Sponsor
- AMNEAL PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CAPECITABINE | CAPECITABINE | TABLET;ORAL | 150MG | No | No |
| 002 | CAPECITABINE | CAPECITABINE | TABLET;ORAL | 500MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A204741-001 | CAPECITABINE | CAPECITABINE | 150MG | TABLET / ORAL | 2017-02-28 | ||
| A204741-002 | CAPECITABINE | CAPECITABINE | 500MG | TABLET / ORAL | 2017-02-28 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A204741-001 | CAPECITABINE | 150MG | TABLET / ORAL | 2017-02-28 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | A204741-002 | CAPECITABINE | 500MG | TABLET / ORAL | 2017-02-28 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A204741-001 | CAPECITABINE | 150MG | TABLET / ORAL | 2017-02-28 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A204741-002 | CAPECITABINE | 500MG | TABLET / ORAL | 2017-02-28 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A204741-001 | CAPECITABINE | 150MG | TABLET / ORAL | 2017-02-28 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A204741-002 | CAPECITABINE | 500MG | TABLET / ORAL | 2017-02-28 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A204741-001 | CAPECITABINE | 150MG | TABLET / ORAL | 2017-02-28 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A204741-002 | CAPECITABINE | 500MG | TABLET / ORAL | 2017-02-28 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A204741-001 | CAPECITABINE | 150MG | TABLET / ORAL | 2017-02-28 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A204741-002 | CAPECITABINE | 500MG | TABLET / ORAL | 2017-02-28 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A204741-001 | CAPECITABINE | 150MG | TABLET / ORAL | 2017-02-28 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A204741-002 | CAPECITABINE | 500MG | TABLET / ORAL | 2017-02-28 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A204741-001 | CAPECITABINE | 150MG | TABLET / ORAL | 2017-02-28 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A204741-002 | CAPECITABINE | 500MG | TABLET / ORAL | 2017-02-28 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A204741-001 | CAPECITABINE | 150MG | TABLET / ORAL | 2017-02-28 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A204741-002 | CAPECITABINE | 500MG | TABLET / ORAL | 2017-02-28 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A204741-001 | CAPECITABINE | 150MG | TABLET / ORAL | 2017-02-28 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A204741-002 | CAPECITABINE | 500MG | TABLET / ORAL | 2017-02-28 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A204741-001 | CAPECITABINE | 150MG | TABLET / ORAL | 2017-02-28 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A204741-002 | CAPECITABINE | 500MG | TABLET / ORAL | 2017-02-28 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A204741-001 | CAPECITABINE | 150MG | TABLET / ORAL | 2017-02-28 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A204741-002 | CAPECITABINE | 500MG | TABLET / ORAL | 2017-02-28 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A204741-001 | CAPECITABINE | 150MG | TABLET / ORAL | 2017-02-28 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A204741-002 | CAPECITABINE | 500MG | TABLET / ORAL | 2017-02-28 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A204741-001 | CAPECITABINE | 150MG | TABLET / ORAL | 2017-02-28 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A204741-002 | CAPECITABINE | 500MG | TABLET / ORAL | 2017-02-28 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A204741-001 | CAPECITABINE | 150MG | TABLET / ORAL | 2017-02-28 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A204741-002 | CAPECITABINE | 500MG | TABLET / ORAL | 2017-02-28 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A204741-001 | CAPECITABINE | 150MG | TABLET / ORAL | 2017-02-28 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A204741-002 | CAPECITABINE | 500MG | TABLET / ORAL | 2017-02-28 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A204741-001 | CAPECITABINE | 150MG | TABLET / ORAL | AB | 2017-02-28 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A204741-002 | CAPECITABINE | 500MG | TABLET / ORAL | AB | 2017-02-28 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A204741-001 | CAPECITABINE | 150MG | TABLET / ORAL | AB | 2017-02-28 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | A204741-002 | CAPECITABINE | 500MG | TABLET / ORAL | AB | 2017-02-28 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A204741-001 | CAPECITABINE | 150MG | TABLET / ORAL | AB | 2017-02-28 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | A204741-002 | CAPECITABINE | 500MG | TABLET / ORAL | AB | 2017-02-28 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | A204741-001 | CAPECITABINE | 150MG | TABLET / ORAL | AB | 2017-02-28 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | A204741-002 | CAPECITABINE | 500MG | TABLET / ORAL | AB | 2017-02-28 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | A204741-001 | CAPECITABINE | 150MG | TABLET / ORAL | AB | 2017-02-28 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | A204741-002 | CAPECITABINE | 500MG | TABLET / ORAL | AB | 2017-02-28 | bb7c543d1eb4… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A204741-001 | AB | 1 | 5c6f7cd8ea54… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A204741-002 | AB | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A204741-001 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-08 23:34 UTC | 2022-04 | A204741-002 | AB | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A204741-001 | AB | 1 | 4b0b4de00fa7… |
| 2022-04-04 05:41 UTC | 2022-04 | A204741-002 | AB | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A204741-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A204741-002 | AB | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A204741-001 | AB | 1 | bb7c543d1eb4… |
| 2022-03-09 01:35 UTC | 2022-03 | A204741-002 | AB | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A204741-001 | AB | 1 | 782e0a99824c… |
| 2021-12-28 21:50 UTC | 2021-12 | A204741-002 | AB | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A204741-001 | AB | 1 | 87673890dc5c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A204741-002 | AB | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A204741-001 | AB | 1 | 5aa47cf7b7d7… |
| 2021-03-12 10:30 UTC | 2021-03 | A204741-002 | AB | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A204741-001 | AB | 1 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | A204741-002 | AB | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A204741-001 | AB | 1 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | A204741-002 | AB | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A204741-001 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A204741-002 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A204741-001 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A204741-002 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A204741-001 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A204741-002 | AB | 1 | ea99ee380514… |
| 2022-09-29 23:25 UTC | 2022-09 | A204741-001 | AB | 1 | e64feba35796… |
| 2022-09-29 23:25 UTC | 2022-09 | A204741-002 | AB | 1 | e64feba35796… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A204741-001 | AB | 1 | cb3db0bc1861… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A204741-002 | AB | 1 | cb3db0bc1861… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| capecitabine | CAPECITABINE | NorthStar RxLLC | 0b59e98c-5b34-4b93-90f6-20526f4d4f88 | 2026-07-21 | Boxed warning, Warnings, Adverse reactions | capecitabine CAPECITABINE |
| Capecitabine | CAPECITABINE | Aurobindo Pharma Limited | 56441153-a1e5-4fdc-96d6-f21baa6b5fbe | 2026-07-08 | Boxed warning, Warnings, Adverse reactions | Capecitabine CAPECITABINE |
| Capecitabine | CAPECITABINE | Ascend Laboratories, LLC | 06a88b03-6c06-4dae-b3bc-1e8dd81c9067 | 2026-06-17 | Boxed warning, Warnings, Adverse reactions | Capecitabine CAPECITABINE |
| capecitabine | CAPECITABINE | Camber Pharmaceuticals, Inc. | 3e7d6317-1439-4976-ae00-6f62619ec3dd | 2026-05-12 | Boxed warning, Warnings, Adverse reactions | capecitabine CAPECITABINE |
| Capecitabine | CAPECITABINE | Golden State Medical Supply, Inc. | e28a5ef7-4731-f8ac-e053-2995a90a21bf | 2026-04-16 | Boxed warning, Warnings, Adverse reactions | Capecitabine CAPECITABINE |
| XELODA | CAPECITABINE | H2-Pharma, LLC | e702d84d-7162-4751-bf37-d724cc7e45a5 | 2026-02-05 | Boxed warning, Warnings, Adverse reactions | CAPECITABINE |
| Capecitabine | CAPECITABINE | BluePoint Laboratories | 88c5af84-900a-4372-b056-bfea70c129cf | 2026-01-29 | Boxed warning, Warnings, Adverse reactions | Capecitabine CAPECITABINE |
| Capecitabine | CAPECITABINE | Teva Pharmaceuticals USA, Inc. | 5753679a-506c-4ac4-b8b2-b27c664d1d40 | 2025-12-31 | Boxed warning, Warnings, Adverse reactions | Capecitabine CAPECITABINE |
| capecitabine | CAPECITABINE | Dr. Reddy's Laboratories Limited | 007e3432-c8aa-2a76-52ba-c346924c08a7 | 2025-11-20 | Boxed warning, Warnings, Adverse reactions | capecitabine CAPECITABINE |
| Capecitabine | CAPECITABINE | Quallent Pharmaceuticals Health LLC | d23f023a-ea62-4ac0-f615-d5d26d59526d | 2025-11-20 | Boxed warning, Warnings, Adverse reactions | Capecitabine CAPECITABINE |
| Capecitabine | CAPECITABINE | Lifestar Pharma LLC | 643a31d6-0e30-4602-a9b4-355fe944bfea | 2025-11-03 | Boxed warning, Warnings, Adverse reactions | Capecitabine CAPECITABINE |
| Capecitabine | CAPECITABINE | American Health Packaging | 2777b481-7d7f-461a-b5e0-c09ce2990c34 | 2025-08-20 | Boxed warning, Warnings, Adverse reactions | Capecitabine CAPECITABINE |
| Capecitabine | CAPECITABINE | CivicaScript LLC | 4ec2cfc1-e8ca-4109-8b90-1aab07cbab21 | 2025-06-25 | Boxed warning, Warnings, Adverse reactions | Capecitabine CAPECITABINE |
| Capecitabine | CAPECITABINE | Teyro Labs Private Limited | 0c873e5b-51c2-4685-86c5-53f98563b093 | 2025-01-08 | Boxed warning, Warnings, Adverse reactions | Capecitabine CAPECITABINE |
| Capecitabine | CAPECITABINE | Novadoz Pharmaceuticals LLC | 29885ada-b743-419c-8f15-edd4247c76ca | 2024-05-11 | Boxed warning, Warnings, Adverse reactions | Capecitabine CAPECITABINE |
| CAPECITABINE | CAPECITABINE | Accord Healthcare Inc. | 8345d55e-ad02-4726-a04b-1a46e3337a4b | 2024-01-04 | Boxed warning, Warnings, Adverse reactions | CAPECITABINE CAPECITABINE |
| Capecitabine | CAPECITABINE | Sun Pharmaceutical Industries, Inc. | e3b1a2b5-f1ce-45ea-afd8-68aac53665fa | 2023-06-06 | Boxed warning, Warnings, Adverse reactions | Capecitabine CAPECITABINE |
| Capecitabine | CAPECITABINE | Cipla USA Inc. | 2871c37d-5e55-437b-a434-fc86d845492a | 2023-06-06 | Boxed warning, Warnings, Adverse reactions | Capecitabine CAPECITABINE |
| CAPECITABINE | CAPECITABINE | BluePoint Laboratories | bbb12406-ce02-3f31-e053-2995a90a0b16 | 2023-05-31 | Boxed warning, Warnings, Adverse reactions | CAPECITABINE CAPECITABINE |
| Capecitabine 500mg | CAPECITABINE | Armas Pharmaceuticals Inc. | f050d16c-ab76-489d-b92c-8c155b4e3f7c | 2020-12-26 | Boxed warning, Warnings, Adverse reactions | CAPECITABINE |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 42291-167 | Capecitabine | Capecitabine | AvKARE, Inc. | ANDA | Current |
| 50268-154 | Capecitabine | Capecitabine | AvPAK | ANDA | Current |
| 50268-154 | Capecitabine | Capecitabine | AvPAK | ANDA | Current |
| 50268-154 | Capecitabine | Capecitabine | AvPAK | ANDA | Current |
| 65162-843 | Capecitabine | Capecitabine | Amneal Pharmaceuticals LLC | ANDA | Current |
| 65162-843 | Capecitabine | Capecitabine | Amneal Pharmaceuticals LLC | ANDA | Current |
| 65162-843 | Capecitabine | Capecitabine | Amneal Pharmaceuticals LL | ANDA | Current |
| 65162-843 | Capecitabine | Capecitabine | Amneal Pharmaceuticals LLC | ANDA | Current |
| 65162-843 | Capecitabine | Capecitabine | Amneal Pharmaceuticals LLC | ANDA | Current |
| 65162-844 | Capecitabine | Capecitabine | Amneal Pharmaceuticals LLC | ANDA | Current |
| 65162-844 | Capecitabine | Capecitabine | Amneal Pharmaceuticals LLC | ANDA | Current |
| 65162-844 | Capecitabine | Capecitabine | Amneal Pharmaceuticals LL | ANDA | Current |
| 65162-844 | Capecitabine | Capecitabine | Amneal Pharmaceuticals LLC | ANDA | Current |
| 65162-844 | Capecitabine | Capecitabine | Amneal Pharmaceuticals LLC | ANDA | Current |